Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
Features of Individualized Medication Guidance for Prostate Cancer DiagnosisTargeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use.
Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy.
Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs.
Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor history and other information.
Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis, Prostate Cancer Prevention, Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website.
As an ivd in vitro diagnosticcompany, we can offer sorts of ivd in vitro diagnosticequipment for sale, if you are interested, please leave us a message.
在线联系供应商
Other supplier products
 |
The Disease Susceptibility Genetic Test-Esophageal Cancer | The Disease Susceptibility Genetic Test-Esophageal Cancer This genetic testing for esophageal cancerbases on biochip precise healthcare solutions ... |
 |
CNV-seq Detection (Semiconductor Sequencing) | CNV-seq Detection (Semiconductor Sequencing) The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome... |
 |
Genetic Testing for Hereditary Breast/Ovarian Cancer(BRCA1/2) | According to research reports, individuals with inherited cancer genes have a higher risk of cancer than ordinary people. About 7% of breast cancer... |
 |
Individualized Medication Guidance for Cancer (118 Genes) | This cancer genetic testdetects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlati... |
 |
Forensic Platform | Forensic DNA identification is a scientific and technological weapon for investigation and litigation. The inspection includes DNA extraction, PCR ... |
Same products
 |
SPC Wall Panel | 卖方: 浙江海利得新材料股份有限公司 | SPC Wall Panel is a new solution to take replacement of tiles, marble, ceramics. It’s w... |
 |
Resilient Flooring | 卖方: 浙江海利得新材料股份有限公司 | Halead (Hailide) flooring was set up by Halead Group in 2014. With a total investment of 70M USD,... |
 |
数字轨道直边测量仪 | 卖方: 武汉联科瑞际轨道设备有限公司 | |
 |
DG-I Gantry Crane Rail Changer | 卖方: 武汉联科瑞际轨道设备有限公司 | |
 |
便携式轨道垂直捣固机 | 卖方: 武汉联科瑞际轨道设备有限公司 |
